Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
about
Evidence of platelet activation in multiple sclerosisInfusible platelet membrane as a platelet substitute for transfusion: an overviewPlatelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase.Cell damage at the origin of antiphospholipid antibodies and their pathogenic potential in recurrent pregnancy lossAntiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopeniaPathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Thromboelastometric and platelet responses to silk biomaterialsImmune thrombocytopenic purpura masking the fatal potential of calciphylaxis in a haemodialysis patientCellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy.CLEC-2 expression is maintained on activated platelets and on platelet microparticles.Microparticles in stored red blood cells as potential mediators of transfusion complicationsIn vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.β3 phosphorylation of platelet αIIbβ3 is crucial for stability of arterial thrombus and microparticle formation in vivo.Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma.Association between vascular access failure and microparticles in hemodialysis patients.The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membraneCirculating red cell-derived microparticles in human malaria.Thrombotic Paradox: Ischaemic Stroke in Immune Thrombocytopaenia. A Case Report and Review.Development and implementation of a novel immune thrombocytopenia bleeding score for dogs.
P2860
Q21245238-C5C72A71-8921-4E55-8773-45FEBAFA3E7CQ26861577-B87FF075-B14A-42CD-A80C-C63ECA07D850Q33375459-A524B5C1-958F-4297-9124-A01D81DDE139Q33379576-2D5828D2-4B10-414C-AE07-331D741AA744Q33390126-7A74DD9C-6DC8-4D82-A1E2-0227BD251FE1Q33439412-05C33048-7950-4825-80F4-A59B9CC010D8Q33602094-8FDDC437-8C5F-4844-B84E-9A043CC75F72Q33622310-7E7D65CB-BF77-480A-8255-50E1F1254195Q34160603-9D2CC4F6-29AD-4AD3-89D4-E07339453114Q34284335-2AADA59B-56BB-4398-9075-29A8817CA91BQ34983553-AB9DCE47-928D-4FF4-84D3-A48658E067F1Q40851071-4AAA4B88-0243-4F88-A96A-583E1775887CQ41558378-2CF03383-56F4-4E9E-BAE1-8C101F2D173FQ42094457-10DB1300-1BF8-4939-8B71-CCB9CEDABB11Q42129359-9BDD86A4-E9F8-4367-94C0-D9DEBC97B50EQ42161015-FF111D73-1742-4637-B2B1-FB1526B60604Q42712727-737E6CA9-84DE-4B26-BD48-60529E766307Q49860813-22A4969B-E640-4AB7-8D86-73B245000EF4Q52571913-84D3F14C-6E80-4782-8079-9057CD62512B
P2860
Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
@ast
Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
@en
type
label
Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
@ast
Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
@en
prefLabel
Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
@ast
Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
@en
P2093
P1476
Clinical significance of platelet microparticles in autoimmune thrombocytopenias.
@en
P2093
P304
P577
1992-04-01T00:00:00Z